KRUK Spólka Akcyjna (KRKKF) Q2 2026 Earnings Call Transcript

KRUK reported PLN 555 million net profit for the first six months of 2026—solid, but flat versus the prior year as growth is expected in the second half. Cash EBITDA rose 8% and recoveries increased 5%, while assets grew 12% to support future revenue growth; management cited Romanian currency depreciation versus the euro and slightly lower-than-planned recoveries (about 2% lower than expected) as key drags. The company also secured ~PLN 860 million of new investments and indicated leverage remains contained at ~2.6x, with upside tied to recovery performance.

Analysis

This reads as a quality-of-earnings update, not a thesis break. The market should care less about the flat first-half profit print and more about the embedded option value in the enlarged asset base: in this model, today’s deployment drives 12-24 month cash flow, while a small recovery miss mainly shifts timing unless purchase yields are compressing. The fact that leverage is still below a constraint level suggests the balance sheet is being held ready for another leg of deployment, which matters because the next vintage of purchased receivables is likely to be the real EPS driver into 2027.

The biggest near-term risk is translation and timing, not solvency. FX weakness in the Romanian book can obscure underlying collection performance for one to two quarters, while even modest recovery shortfalls can trigger multiple compression if investors anchor on reported profit instead of cash EBITDA. Conversely, if management executes on higher investment pace, the second-order winner is future servicing income and recoveries; the first-order loser is any competitor bidding aggressively on the same portfolios, since a disciplined buyer with balance-sheet room can outlast higher-cost capital.

Consensus may be underestimating how convex the setup is to a better H2 and a steadier FX backdrop. The key question is whether the company can keep buying assets at acceptable IRRs without overpaying as capital becomes more available in distressed credit. If deployment remains strong and recoveries simply revert to plan, the market can re-rate the shares on forward FCF rather than trailing net profit; if not, the stock likely stays rangebound because the current quarter did not provide enough evidence of acceleration.

Key Decisions for Investors

• Bias to accumulate KRKKF/KRUK on post-earnings weakness over the next 1-2 weeks if the stock sells off on the flat profit headline; the setup is better for 2H cash flow than for headline EPS, with a 6-18 month horizon.
• Pair trade: long KRUK vs short Intrum or PRAA on a 3-6 month view, expressing the view that better-capitalized buyers with room to deploy should compound faster than more levered peers if distressed credit supply remains available.
• Watch item, not immediate trade: if Romanian FX stabilizes and collections trend back to the 5% recovery-plan range over the next 1-2 quarters, add exposure; if FX or recoveries deteriorate again, the thesis weakens and the stock should be treated as range-bound.
• For investors able to use options on the local line, consider a modest call spread into the next operating update rather than outright stock, because the main upside catalyst is a confirmation of H2 acceleration while downside is mostly timing-related.
• Set a thesis-falsifier alert on leverage and deployment: if net leverage starts rising without a corresponding increase in new investments or if recovery rates fail to improve despite a larger asset base, cut the position; that would imply capital is not compounding at the expected rate.